Evolutionary voting kernel machines for cyclooxygenase-2 inhibitor activity comparisons

被引:0
|
作者
Jin, Bo [1 ]
Zhang, Yan-Qing [1 ]
机构
[1] Georgia State Univ, Dept Comp Sci, Atlanta, GA 30302 USA
关键词
drug activity comparisons; kernel; genetic algorithms; granular kernel trees; support vector machines;
D O I
暂无
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
With the growing interest of biological data prediction and chemical data prediction, more complicated kernels are designed to measure data similarities. In [1], we proposed a kind of evolutionary granular kernel trees (EGKTs) for drug activity comparisons. In EGKTs, feature granules and tree structures are predefined based on the possible substituent locations. In [2], we proposed a granular kernel tree structure evolving system (GKTSES) to evolve the structures of GKTs in the case that we lack knowledge to predefine kernel trees. In this paper, evolutionary voting kernel machines (EVKMs) are presented based on GKTSES. Experimental results show that EVKMs are more stable than GKTSES in cyclooxygenase-2 inhibitor activity comparisons.
引用
收藏
页码:671 / +
页数:2
相关论文
共 50 条
  • [21] Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
    Zhi-Jun Dai
    Xiao-Bin Ma
    Hua-Feng Kang
    Jie Gao
    Wei-Li Min
    Hai-Tao Guan
    Yan Diao
    Wang-Feng Lu
    Xi-Jing Wang
    Cancer Cell International, 12
  • [22] Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
    Dai, Zhi-Jun
    Ma, Xiao-Bin
    Kang, Hua-Feng
    Gao, Jie
    Min, Wei-Li
    Guan, Hai-Tao
    Diao, Yan
    Lu, Wang-Feng
    Wang, Xi-Jing
    CANCER CELL INTERNATIONAL, 2012, 12
  • [23] Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man
    Cheremina, O.
    Brune, K.
    Hinz, B.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 96 - 96
  • [24] Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor
    Kishi, K
    Petersen, S
    Petersen, C
    Hunter, N
    Mason, K
    Masferrer, JL
    Tofilon, PJ
    Milas, L
    CANCER RESEARCH, 2000, 60 (05) : 1326 - 1331
  • [25] Risk of myocardial infarction by type of cyclooxygenase-2 inhibitor
    Kimmel, SE
    Berlin, JA
    Reilly, M
    Jaskowiak, J
    Kishel, L
    Strom, BL
    CIRCULATION, 2003, 108 (17) : 752 - 752
  • [26] Etoricoxib -: Analgesic drug, antiarthritic, cyclooxygenase-2 inhibitor
    Sorbera, LA
    Castañer, RM
    Silvestre, J
    Castañer, J
    DRUGS OF THE FUTURE, 2001, 26 (04) : 346 - 353
  • [27] The effect of cyclooxygenase-2 inhibitor on experimental allergic neuritis
    Miyamoto, K
    Oka, N
    Kawasaki, T
    Satoi, H
    Akiguchi, I
    Kimura, J
    NEUROREPORT, 1998, 9 (10) : 2331 - 2334
  • [28] Severe oligohydramnios induced by cyclooxygenase-2 inhibitor nimesulide
    Holmes, RP
    Stone, PR
    OBSTETRICS AND GYNECOLOGY, 2000, 96 (05): : 810 - 811
  • [29] Cyclooxygenase-2 inhibitor delays fracture healing in rats
    Endo, K
    Sairyo, K
    Komatsubara, S
    Sasa, T
    Egawa, H
    Ogawa, T
    Yonekura, D
    Murakami, RI
    Yasui, N
    ACTA ORTHOPAEDICA, 2005, 76 (04) : 470 - 474
  • [30] Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man
    Hinz, Burkhard
    Cheremina, Olga
    Brune, Kay
    FASEB JOURNAL, 2008, 22 (02): : 383 - 390